Condition
Neurogenic Bladder (NB)
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Early P 1 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07643974Early Phase 1Not Yet Recruiting
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD
NCT07639541Not ApplicableNot Yet Recruiting
Radio-frequency (RF) Bladder Monitor
NCT07264868Not ApplicableRecruiting
Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury
Showing all 3 trials